-
Je něco špatně v tomto záznamu ?
Effect of chronic continuous normobaric hypoxia on functional state of cardiac mitochondria and tolerance of isolated rat heart to ischemia and reperfusion: role of µ and delta2 opioid receptors
E. S. Prokudina, N. V. Naryzhnaya, A. V. Mukhomedzyanov, A. S. Gorbunov, Y. Zhang, A. S. Jaggi, S. Y. Tsibulnikov, E. A. Nesterov, Y. B. Lishmanov, M. S. Suleiman, P. R. Oeltgen, L. N. Maslov
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- hypoxie patofyziologie MeSH
- krysa rodu rattus MeSH
- narkotika - antagonisté farmakologie MeSH
- orgánové kultury - kultivační techniky MeSH
- potkani Wistar MeSH
- receptory opiátové delta antagonisté a inhibitory fyziologie MeSH
- receptory opiátové mu antagonisté a inhibitory fyziologie MeSH
- reperfuzní poškození myokardu patofyziologie prevence a kontrola MeSH
- srdeční mitochondrie účinky léků fyziologie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
Chronic continuous normobaric hypoxia (CNH) increases cardiac tolerance to ischemia/reperfusion injury in vivo and this effect is mediated via µ and delta2 opioid receptors (ORs) activation. CNH has also been shown to be cardioprotective in isolated rat heart. In this study, we hypothesize that this cardioprotective effect of CNH is mediated by activation of µ and delta2 ORs and preservation of mitochondrial function. Hearts from rats adapted to CNH (12 % oxygen) for 3 weeks were extracted, perfused in the Langendorff mode and subjected to 45 min of global ischemia and 30 min of reperfusion. Intervention groups were pretreated for 10 min with antagonists for different OR types: naloxone (300 nmol/l), the selective delta OR antagonist TIPP(psi) (30 nmol/l), the selective delta1 OR antagonist BNTX (1 nmol/l), the selective delta2 OR antagonist naltriben (1 nmol/l), the selective peptide µ OR antagonist CTAP (100 nmol/l) and the selective delta OR antagonist nor-binaltorphimine (3 nmol/l). Creatine kinase activity in coronary effluent and cardiac contractile function were monitored to assess cardiac injury and functional impairment. Additionally, cardiac tissue was collected to measure ATP and to isolate mitochondria to measure respiration rate and calcium retention capacity. Adaptation to CNH decreased myocardial creatine kinase release during reperfusion and improved the postischemic recovery of contractile function. Additionally, CNH improved mitochondrial state 3 and uncoupled respiration rates, ADP/O, mitochondrial transmembrane potential and calcium retention capacity and myocardial ATP level during reperfusion compared to the normoxic group. These protective effects were completely abolished by naloxone, TIPP(psi), naltriben, CTAP but not BNTX or nor-binaltorphimine. These results suggest that cardioprotection associated with adaptation to CNH is mediated by µ and delta2 opioid receptors activation and preservation of mitochondrial function.
Department of Pathology University of Kentucky College of Medicine Lexington KY USA
Department of Pharmaceutical Sciences and Drug Research Punjabi University Patiala India
Department of Physiology Hebei Medical University Shijiazhuang China
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20010290
- 003
- CZ-PrNML
- 005
- 20200720141430.0
- 007
- ta
- 008
- 200707s2019 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933945 $2 doi
- 035 __
- $a (PubMed)31647288
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Prokudina, E. S. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia
- 245 10
- $a Effect of chronic continuous normobaric hypoxia on functional state of cardiac mitochondria and tolerance of isolated rat heart to ischemia and reperfusion: role of µ and delta2 opioid receptors / $c E. S. Prokudina, N. V. Naryzhnaya, A. V. Mukhomedzyanov, A. S. Gorbunov, Y. Zhang, A. S. Jaggi, S. Y. Tsibulnikov, E. A. Nesterov, Y. B. Lishmanov, M. S. Suleiman, P. R. Oeltgen, L. N. Maslov
- 504 __
- $a Literatura
- 520 9_
- $a Chronic continuous normobaric hypoxia (CNH) increases cardiac tolerance to ischemia/reperfusion injury in vivo and this effect is mediated via µ and delta2 opioid receptors (ORs) activation. CNH has also been shown to be cardioprotective in isolated rat heart. In this study, we hypothesize that this cardioprotective effect of CNH is mediated by activation of µ and delta2 ORs and preservation of mitochondrial function. Hearts from rats adapted to CNH (12 % oxygen) for 3 weeks were extracted, perfused in the Langendorff mode and subjected to 45 min of global ischemia and 30 min of reperfusion. Intervention groups were pretreated for 10 min with antagonists for different OR types: naloxone (300 nmol/l), the selective delta OR antagonist TIPP(psi) (30 nmol/l), the selective delta1 OR antagonist BNTX (1 nmol/l), the selective delta2 OR antagonist naltriben (1 nmol/l), the selective peptide µ OR antagonist CTAP (100 nmol/l) and the selective delta OR antagonist nor-binaltorphimine (3 nmol/l). Creatine kinase activity in coronary effluent and cardiac contractile function were monitored to assess cardiac injury and functional impairment. Additionally, cardiac tissue was collected to measure ATP and to isolate mitochondria to measure respiration rate and calcium retention capacity. Adaptation to CNH decreased myocardial creatine kinase release during reperfusion and improved the postischemic recovery of contractile function. Additionally, CNH improved mitochondrial state 3 and uncoupled respiration rates, ADP/O, mitochondrial transmembrane potential and calcium retention capacity and myocardial ATP level during reperfusion compared to the normoxic group. These protective effects were completely abolished by naloxone, TIPP(psi), naltriben, CTAP but not BNTX or nor-binaltorphimine. These results suggest that cardioprotection associated with adaptation to CNH is mediated by µ and delta2 opioid receptors activation and preservation of mitochondrial function.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a hypoxie $x patofyziologie $7 D000860
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a srdeční mitochondrie $x účinky léků $x fyziologie $7 D008929
- 650 _2
- $a reperfuzní poškození myokardu $x patofyziologie $x prevence a kontrola $7 D015428
- 650 _2
- $a narkotika - antagonisté $x farmakologie $7 D009292
- 650 _2
- $a orgánové kultury - kultivační techniky $7 D009924
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory opiátové delta $x antagonisté a inhibitory $x fyziologie $7 D017465
- 650 _2
- $a receptory opiátové mu $x antagonisté a inhibitory $x fyziologie $7 D017450
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Naryzhnaya, N. V. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia
- 700 1_
- $a Mukhomedzyanov, A. V. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia
- 700 1_
- $a Gorbunov, A. S. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia
- 700 1_
- $a Zhang, Y. $u Department of Physiology, Hebei Medical University, Shijiazhuang, China
- 700 1_
- $a Jaggi, A. S. $u Department of Pharmaceutical Sciences and Drug Research, Punjabi University Patiala, India
- 700 1_
- $a Tsibulnikov, S. Y. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia
- 700 1_
- $a Nesterov, E. A. $u Tomsk Polytechnic University. Tomsk, Russia
- 700 1_
- $a Lishmanov, Y. B. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia; Tomsk Polytechnic University. Tomsk, Russia
- 700 1_
- $a Suleiman, M. S. $u Bristol Heart Institute, School of Clinical Sciences, Faculty of Medicine and Dentistry, University of Bristol, Bristol, United Kingdom
- 700 1_
- $a Oeltgen, P. R. $u Department of Pathology, University of Kentucky College of Medicine, Lexington, KY, USA
- 700 1_
- $a Maslov, L. N. $u Laboratory of Experimental Cardiology, Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences, Tomsk, Russia
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 68, č. 6 (2019), s. 909-920
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31647288 $y Pubmed
- 910 __
- $a ABA008 $b A 4120 $c 266 $y p $z 0
- 990 __
- $a 20200707 $b ABA008
- 991 __
- $a 20200720110353 $b ABA008
- 999 __
- $a ok $b bmc $g 1545949 $s 1100382
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 68 $c 6 $d 909-920 $e 20191025 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- LZP __
- $b NLK118 $a Pubmed-20200707